Newsletter Signup | Join Community
NSAIDs Decrease Risk of Colorectal Cancer.
Proton Beam Therapy may Improve Outcomes for Rectal Cancer.
NCCN Guidelines® Recommend SIR-Spheres® Y-90 Resin Microspheres
Herceptin® Plus Tykerb® Promising for HER2-Positive Colorectal Cancer
Lonsurf® Approved for the Treatment of Colorectal Cancer
XBiotech Completes Enrollment for Xilonix™ Phase III Registration Study in Europe, US Trial Ongoing
New Biomarkers Might Help Personalize Metastatic Colorectal Cancer Treatment
New Drug Combination Extends Survival of Patients with Metastatic Colorectal Cancer
Encouraging Overall Survival and Well-Being for Xilonix™ in Advanced Colorectal Cancer
Cyramza Added to FOLFIRI Delays Disease Progression and Extends Survival for Patients With Advanced Colorectal Cancer